Literature DB >> 21148561

JHDM3A module as an effector molecule in guide-directed modification of target chromatin.

Young Sun Jeong1, Jung Sun Park, Yong Ko, Yong-Kook Kang.   

Abstract

With the objective of returning cells to their undifferentiated state through alteration of epigenetic states, small molecules have been used that specifically inhibit proteins involved in sustaining the epigenetic system. However, this chemical-based approach can cause chaotic epigenomic states due to random actions of the inhibitors. We investigated whether JHDM3A/JMJD2A, a trimethylated histone H3-lysine 9 (H3K9me3)-specific demethylase, could function as an effector molecule to selectively demethylate target chromatin, with the aid of a guide protein to serve as a delivery vehicle. JHDM3A, which normally locates in euchromatin, spread out to heterochromatin when it was fused to heterochromatin protein-1α (HP1α) or HP1β; in these cells, demethylation efficiency was also markedly increased. Two truncated modules, JHDM3A(GFP)(406) and JHDM3A(GFP)(701), had contrasting modes and efficiencies of H3K9me3 demethylation; JHDM3A(GFP)(406) showed a very uniform rate (∼80%) of demethylation, whereas JHDM3A(GFP)(701) had a broad methylation range of 4-80%. The methylation values were highly dependent on the presence of the guide proteins OCT4, CTCF, and HP1. Chromatin immunoprecipitation detected reduced H3K9me3 levels at OCT4 regulatory loci in the cells expressing OCT4-tagged JHDM3A(GFP)(701). Derepression of the Sox2 gene was observed in JHDM3A(GFP)(701)OCT4-expressing cells, but not in cells that expressed the JHDM3A(GFP)(701) module alone. JHDM3A(GFP)(701)-assisted OCT4 more efficiently turned on stem cell-related microRNAs than GFP-OCT4 itself. These results suggest that JHDM3A(GFP)(701) is a suitable catalytic module that can be targeted, under the control of a guide protein, to specific loci where the chromatin H3K9me3 status and the milieu of gene expression are to be modified.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148561      PMCID: PMC3039326          DOI: 10.1074/jbc.M110.176040

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  We gather together: insulators and genome organization.

Authors:  Julie A Wallace; Gary Felsenfeld
Journal:  Curr Opin Genet Dev       Date:  2007-10-24       Impact factor: 5.578

Review 2.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

3.  Viable offspring derived from fetal and adult mammalian cells.

Authors:  I Wilmut; A E Schnieke; J McWhir; A J Kind; K H Campbell
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

4.  The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.

Authors:  Robert J Klose; Kenichi Yamane; Yangjin Bae; Dianzheng Zhang; Hediye Erdjument-Bromage; Paul Tempst; Jiemin Wong; Yi Zhang
Journal:  Nature       Date:  2006-05-28       Impact factor: 49.962

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.

Authors:  Johnathan R Whetstine; Amanda Nottke; Fei Lan; Maite Huarte; Sarit Smolikov; Zhongzhou Chen; Eric Spooner; En Li; Gongyi Zhang; Monica Colaiacovo; Yang Shi
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

7.  Methylation changes of lysine 9 of histone H3 during preimplantation mouse development.

Authors:  Seungeun Yeo; Kyung-Kwang Lee; Yong-Mahn Han; Yong-Kook Kang
Journal:  Mol Cells       Date:  2005-12-31       Impact factor: 5.034

8.  Structural insights into histone demethylation by JMJD2 family members.

Authors:  Zhongzhou Chen; Jianye Zang; Johnathan Whetstine; Xia Hong; Foteini Davrazou; Tatiana G Kutateladze; Michael Simpson; Qilong Mao; Cheol-Ho Pan; Shaodong Dai; James Hagman; Kirk Hansen; Yang Shi; Gongyi Zhang
Journal:  Cell       Date:  2006-05-04       Impact factor: 41.582

9.  Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter.

Authors:  Li-Peng Wu; Xi Wang; Lian Li; Ying Zhao; Shaoli Lu; Yu Yu; Wen Zhou; Xiangyu Liu; Jing Yang; Zhixin Zheng; Hui Zhang; Jingnan Feng; Yang Yang; Haiying Wang; Wei-Guo Zhu
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

10.  Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells.

Authors:  Gerwin Heller; Wolfgang M Schmidt; Barbara Ziegler; Sonja Holzer; Leonhard Müllauer; Martin Bilban; Christoph C Zielinski; Johannes Drach; Sabine Zöchbauer-Müller
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

View more
  1 in total

1.  CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines.

Authors:  Lissania Guerra-Calderas; Rodrigo González-Barrios; Carlos César Patiño; Nicolás Alcaraz; Marisol Salgado-Albarrán; David Cantú de León; Clementina Castro Hernández; Yesennia Sánchez-Pérez; Héctor Aquiles Maldonado-Martínez; Inti A De la Rosa-Velazquez; Fernanda Vargas-Romero; Luis A Herrera; Alejandro García-Carrancá; Ernesto Soto-Reyes
Journal:  Oncotarget       Date:  2018-03-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.